‘Toxic’ Molecule Performs Very important Position in Gene Regulation and Improvement 

A molecule as soon as regarded as a dangerous metabolic byproduct could play an important position in early growth and gene regulation, in keeping with a brand new research published in Nature that challenges many years of biochemical assumptions. 

In the research, Northwestern Medicine investigators discovered that L‑2‑hydroxyglutarate (L‑2‑HG) — a compound beforehand related to uncommon metabolic issues — acts as a signaling molecule that helps regulate gene expression and helps regular progress in mice.  

The findings recommend that some metabolites as soon as regarded as purely poisonous could have essential physiologic capabilities, stated Navdeep Chandel, PhD, professor of Biochemistry and Molecular Genetics and senior writer of the brand new research.  

“This metabolite previously was described as a toxic metabolite, and not part of regular physiology,” stated Chandel, who can also be the David W. Cugell, MD, Professor of Medicine within the Division of Pulmonary and Critical Care and an investigator with the Chan Zuckerberg Initiative. “In this case, it’s involved in kidney development, which we found.” 

For years, L‑2‑HG has been seen primarily as a metabolic waste. In wholesome cells, the molecule is saved at extraordinarily low ranges by an enzyme known as L‑2‑HG dehydrogenase (L2HGDH), which converts it into one other compound, 2‑oxoglutarate. When this course of fails in people, the ensuing buildup of L-2-HG causes a uncommon neurological dysfunction. 

Because of this, scientists have largely handled L‑2‑HG as a dangerous byproduct. But the brand new research reframes that narrative.  

“We generally think everything is about your genes, right? You turn on a gene, you turn off a gene,” Chandel stated. “And then there’s metabolism, that’s just for energy. What we found is that your mitochondria can also dictate those gene responses. It’s just not a passive player.” 

To determine how L‑2‑HG capabilities, investigators mapped its interactions with proteins and found it targets a household of enzymes that regulate gene exercise by modifying chromatin. 

In collaboration with the laboratory of Ali Shilatifard, PhD, the Robert Francis Furchgott Professor and chair of Biochemistry and Molecular Genetics and director of the Simpson Querrey Institute for Epigenetics, who was a co-author of the research, investigators discovered that L-2‑HG inhibits the KDM4 household of demethylases, rising histone H3K9me3, a repressive histone mark that shuts down gene transcription at particular websites.  

“What it does is it shuts off transcription by hitting a particular H3K9 methylation mark,” stated Ram P. Chakrabarty, PhD, a postdoctoral fellow within the Chandel lab, who was first writer of the research.  

In mouse embryonic stem cells, greater L‑2‑HG ranges dampened the exercise of particular genes, confirming its position as a regulator of gene expression. 

“This is an example of a metabolite that we know has nothing to do with generating ATP,” Chandel stated. “It is a metabolite that we now can say is there to communicate between the mitochondria and nucleus to determine cell fate.” 

Mice engineered to cut back L‑2‑HG ranges throughout growth confirmed impaired progress, greater mortality and kidney abnormalities, in keeping with the research. 

“It’s a metabolite that signals and it controls physiology,” Chandel stated. “Because if we just get rid of that metabolite, we get a distinct pathology in the kidney.” 

Further evaluation revealed that low L‑2‑HG disrupted the silencing of retrotransposons — genetic components that may set off irritation if activated. 

“If this metabolite is high, it keeps inflammation down. If this metabolite is low, it allows these retrotransposons to come,” he stated. 

The findings hyperlink metabolism to the management of genomic components not beforehand regarded as metabolically regulated, Chandel stated. The research additionally highlights a broader shift in scientific considering: metabolism isn’t just a help system for mobile perform, however a driver of it. 

“This is probably one of our cleanest examples,” Chandel stated. “This molecule is made, it does its job, then it goes away. And it’s necessary for kidney development specifically.” 

He added that the invention opens up new analysis instructions wherein retrotransposons have been implicated, ranging from most cancers to getting old to immune perform. It additionally raises the likelihood that metabolism could play a broader position in regulating retrotransposons, an idea that stays largely unexplored. 

Additional Feinberg co-authors included Benjamin Singer, ’07 MD, ’10 GME, the Lawrence Hicks Professor of Pulmonary Medicine; Samuel Weinberg, ’19 MD, ’19 PhD, assistant professor of Pathology within the Division of Experimental Pathology; Yuki Aoi, PhD, assistant professor of Medicine and of Biochemistry and Molecular Genetics; Feng Yue, PhD, the Duane and Susan Burnham Professor of Molecular Medicine; Yongchao C. Ma, PhD, affiliate professor of Pediatrics; Marta Iwanaszko, PhD, analysis affiliate professor of Biochemistry and Molecular Genetics; Colleen Reczek, PhD, analysis assistant professor of Medicine within the Division of Pulmonary and Critical Care; Dongmei Wang, PhD, analysis assistant professor of Pathology; Peng Gao, PhD, analysis affiliate professor of Medicine within the Division of Pulmonary and Critical Care; SeungHye Han, MD, MPH, assistant professor of Medicine within the Division of Pulmonary and Critical Care; and Shawn Davidson, PhD, assistant professor of Medicine within the Division of Pulmonary and Critical Care. 

The research was supported by National Institutes of Health (NIH) grants: R01CA290678, P01HL071643, P01AG049665, R01HL149883, R01HL153122, P01HL154998, U19AI135964, U19AI181102, R50CA265372, R01AG077451, R01HL172859, P01HL169188 and T32HL076139.